The Scientist

» nonprofit

Most Recent

image: California Institutes to Merge

California Institutes to Merge

By | October 25, 2016

The Scripps Research Institute will join forces with the California Institute for Biomedical Research.

0 Comments

image: New Scripps Research Institute Leadership

New Scripps Research Institute Leadership

By | September 20, 2015

The nonprofit institution names a new CEO and president.

0 Comments

image: Group Aims for Biomarker Standards

Group Aims for Biomarker Standards

By | January 14, 2014

A new alliance between industry, academia, and the government wants to boost the “dismal” success rate of biomarker development.

0 Comments

image: NFL Gear Yields Little for Cancer

NFL Gear Yields Little for Cancer

By | October 16, 2013

Only a small proportion of money made from breast cancer-themed football merchandise actually supports efforts to combat the disease.  

0 Comments

image: Biology Hacklabs

Biology Hacklabs

By | March 1, 2013

Fueled by donations, sweat, and occasional dumpster diving, community laboratories for DIY biologists are cropping up around the country.

2 Comments

image: The Profits of Nonprofit

The Profits of Nonprofit

By | January 1, 2011

The surprising results when drug development and altruism collide

9 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham